Interest of the Not Invasive Ventilation Used in Meadow and Post-operative of Cardiac Surgery, in Disease Prevention of the Cardiac and/or Lung Complications at the Patients at Risk.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University Hospital, Brest
- Enrollment
- 216
- Locations
- 2
- Primary Endpoint
- Appearance of cardio-pulmonary complications in postoperative cardiac surgery
Study Overview
Brief Summary
After cardiac surgery, many complications can arise, in particular at the cardiac and lung level and it is true especially as the patient is with comorbidity. A patient will be considered at risk of a cardiac surgery if risk factors are present in preoperative (obesity, Chronic obstructive pulmonary disease (COPD), etc...). The non-invasive ventilation (NIV)developed these last years in the treatment of acute cardiac insufficiency and the hypercapnic COPD exacerbations; its use is more and more envisaged in cardio-thoracic and abdominal surgery services.
Studies showed that the NIV allowed an improvement of the oxygenation, the lung volumes and a decrease of ventilation work. According to these observations, the preventive NIV could reduce the incidence of appearance of the lung and/or cardiac complications at the patients to risk. we estimate 40 to 50%of cardiac surgery patients at a high risk level and we expect to obtain a benefit with this particular population. If we meet our goal (a significant difference in terms of morbi-mortality with the preventive NIV versus classical care), we expect the systematisation of this procedure to all cardiac surgery high risk patients.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Every patient of more than 18 years, programmed for a cardiac surgery ( valve replacement, coronary bypass, aortic surgery) in the service of "Chirurgie Cardio-Thoracique et Vasculaire" (CCTV) of the CHRU of Brest
- •and obesity (BMI > 30 kg/m2
- •and/or COPD (stages 1-2 and 3, classification GOLD)
- •and/or restrictive syndrome (CPT 80 %)
- •and/or cardiac insufficiency (FEVG 55 %)
- •and/or syndrome of obesity-hypoventilation not requiring an equipment
- •and/or Syndrome of sleep apnea not requiring an equipment
Exclusion Criteria
- •Patients having a contraindication absolved from the NIV
- •Patients carrier of a neuro-muscular disease
- •Patients carrier of a syndrome of sleep apnea and/or COPD, and sailed
- •Hypercapnic patients (with a limit value of PaCO2 > 55 mm Hg)
- •Unaffiliated patients to a social diet of safety
- •Patients under guardianship or under guardianship
- •Patient who can not follow the NIV program as well as the patients of whom the consent was not collected.
Arms & Interventions
Manufacturer STELLAR 150
5 days of non-invasive ventilation at two levels of pressure from it pre-operative, followed by 5 days in post-operative.
Intervention: Manufacturer STELLAR 150 (Device)
Control Group
Standard preparation
Outcomes
Primary Outcomes
Appearance of cardio-pulmonary complications in postoperative cardiac surgery
Time Frame: 1 month
Appearance of cardio-pulmonary complications in postoperative cardiac surgery among the complications listed below: * Atelectasis * Acute respiratory insufficiency * Acute cardiac insufficiency * Pneumothorax * Arrhythmia * Myocardial infarction * Cardiac tamponade
Secondary Outcomes
- Determine postoperative mortality; length of stay in intensive care, length of stay in the service of CCTV(1 and 3 month)